the aid library

LIST OPTIONS

Filter

7947

Sort by:

Direction:

Download (1502)

View PDF (3100)

Guidance for the Selection and Use of Personal Protective Equipment (PPE) in Healthcare Settings

Centers of Disease Control CDC (2014)

CDC has developed this slide set for use by staff development, infection control, and occupational health personnel for training healthcare personnel on how to select and use personal protective equipment PPE to protect themselves from exposure to microbiological hazards in the healthcare setting

Download (94)

View PDF (896)

Dengue Vaccine | CDC

Centers for Disease Control and Prevention CDC (2023) C2

Website last accessed on 31.03.2023 Dengue vaccine for 9 to 16 year old's with previous dengue infection.

Download (83)

View PDF (613)

Dengue Clinical Case Management course (DCCM)

Centers for Disease Control and Prevention CDC (2020) C_CDC

PROGRAM DESCRIPTION: Course is designed to increase knowledge and develop competency in the management of patients suspected of infection with dengue virus.

Download (150)

View PDF (152)

Preventing and Treating Ear Infections

CDC Centers for Disease Control and Prevention (2019) C_CDC

Is your child’s ear hurting? It could be an ear infection. Children are more likely than adults to get ear infections. Talk to your child’s doctor about the best treatment. Some ear infections, such as middle ear infections, need antibiotic treatment, but many can get better on their own without... more

Download (738)

View PDF (1522)

Information for Ill Travelers: Ebola What you need to do (for travelers with Ebola symtpoms and risk exposures)

Centers for Disease Control and Prevention CDC (2014)

For use with travelers who might have been exposed to patients with Ebola and are sick with symptoms consistent with Ebola infection and require further evaluation

Download (147)

View PDF (885)

Best Practices for Environmental Cleaning in Healthcare Facilities: in Resource-Limited Settings

Centers for Disease Control and Prevention CDC (2019) C_CDC

Healthcare-associated infections (HAI) are a significant burden globally, with millions of patients affected each year. These infections affect both high- and limited-resource healthcare settings, but in limited-resource settings, rates are approximately twice as high as high-resource settings (15 o... more

Download (77)

View PDF (663)

Manufacturing Facility Assessment Toolkit
recommended

Centers for Disease Control and Prevention CDC (2020) CC

Tools and resources for occupational safety and health professionals and state and local public health officials assessing manufacturing facilities. Occupational safety and health professionals and state and local public health officials can use these tools to assess coronavirus disease 2019 (COVID... more

Download (80)

View PDF (1242)

Key messages for professionals in hospitals and other healthcare settings - Website

European Centers for Disease Control and Prevention ECDC (2019) C_CDC

Key messages for professionals working at hospitals and other healthcare settings: managers/administrators, infectious disease specialists, infection prevention and control professionals, epidemiologists, prescribers, junior doctors and students, pharmacists, nurses, clinical microbiologists, and pr... more

Download (109)

View PDF (518)

About Leishmaniasis

Centers for disease control and prevention CDC (2020) C_CDC

Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the bite of infected sand flies. There are several different forms of leishmaniasis in people. The most com... more

Download (119)

View PDF (752)

CDC-DPDx- Leishmaniasis

Division of Parasitic Diseases DPDx Center for Disease Control and Prevention CDC (2017) CC

Leishmaniasis is a vector-borne disease that is transmitted by sandflies and caused by obligate intracellular protozoa of the genus Leishmania. Human infection is caused by about 21 of 30 species that infect mammals. These include the L. donovani complex with 3 species (L. donovani, L. infantum, and... more

Download (113)

View PDF (583)

Parasites - Onchocerciasis (also known as River Blindness)

Center for Disease Control and Prevention CDC (2019) CC

Onchocerciasis, or river blindness, is a neglected tropical disease (NTD) caused by the parasitic worm Onchocerca volvulus. It is transmitted through repeated bites by blackflies of the genus Simulium. The disease is called river blindness because the blackfly that transmits the infection lives and ... more

Download (76)

View PDF (115)

Action Protocol for Enhanced SARI and ILI Surveillance for COVID-19 in Africa

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C2

March 2020 The number of African Union Member States reporting COVID- 19 cases is increasing and there is a likelihood of community transmission. The WHO recently modified the COVID-19 suspect case definition to include severe acute respiratory infection and advises testing of all severe acute res... more

Download (240)

View PDF (168)

Avoid Duplicative Anaerobic Coverage

Centers for Disease Control and Prevention CDC (2019) C_CDC

CDC’s Core Elements of Hospital Antibiotic Stewardship Programs suggests that pharmacists review antibiotic therapy that is unnecessarily duplicative, including the use of agents with overlapping spectra. The combination of two agents with anaerobic activity is unnecessary in most cases. Exception... more

Download (813)

View PDF (1867)

Interim guidance for healthcare providers and Zika virus laboratory diagnosis
recommended

European Centre for Disease Prevention and Control (2016) C1

This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member States. The algorithm is not intended for clinical man... more

Download (444)

View PDF (1964)

Handbook on TB laboratory diagnostic methods in the European Union

European Centre for Disease Prevention and Control (2016) C1

The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological diagnosis of active TB to the diagnosis of latent ... more

Download (38)

View PDF (37)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (90)

View PDF (529)

American Trypanosomiasis (also known as Chagas Disease)

Centers for Disease Control and Prevention CDC (2022) C_CDC

Chagas disease is named after the Brazilian physician Carlos Chagas, who discovered the disease in 1909. It is caused by the parasite Trypanosoma cruzi, which is transmitted to animals and people by insect vectors and is found only in the Americas (mainly, in rural areas of Latin America where pover... more

Download (91)

View PDF (133)

Monitoring and Evaluation of COVID-19 Rapid Antigen Diagnostic Test Rollout in Africa
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2021) C1

Limited coverage of laboratory services and long turnaround times from real-time reverse transcription-polymerase chain reaction (rRT-PCR) for the detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been insufficient to meet the demands in many African countries in response... more

Download (165)

View PDF (163)

A Commitment to Our Patients About Antibiotics

CDC Centers for Disease Control and Prevention (2019) C_CDC

Antibiotics only fight infections caused by bacteria. Like all drugs, they can be harmful and should only be used when necessary. Taking antibiotics when you have a virus can do more harm than good: you will still feel sick and the antibiotic could give you a skin rash, diarrhea, a yeast infection, ... more

Download (718)

View PDF (1363)

Zika virus and safety of substances of human origin – A guide for preparedness activities in Europe

European Centre for Disease Prevention and Control (2016) CC

The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.

Manufacturing Facility Assessment Toolkit recommended

Interim guidance for healthcare providers and Zika virus laboratory diagnosis recommended

Monitoring and Evaluation of COVID-19 Rapid Antigen Diagnostic Test Rollout in Africa recommended

Manufacturing Facility Assessment Toolkit
recommended

Interim guidance for healthcare providers and Zika virus laboratory diagnosis
recommended

Monitoring and Evaluation of COVID-19 Rapid Antigen Diagnostic Test Rollout in Africa
recommended